People of the MedUni Vienna The internationally renowned addiction expert Gabriele Fischer from the University Department of Psychiatry and Psychotherapy and the Centre for Public Health at MedUni Vienna has been nominated once again for the Scientific Advisory Board of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Medicine & Science Using prenatal magnetic resonance imaging, a group of MedUni Vienna researchers examined the placentas and foetuses of women who tested positive for SARS-CoV-2 during pregnancy.

Medicine & Science A research group led by Paul Studenic from the Department of Internal Medicine III at MedUni Vienna has revalidated the remission criteria for rheumatoid arthritis and adapted the definition according to Boolean.

University , Medicine & Science MedUni Vienna awarded Ivo Rausch, Ewald Unger, Alejandra Valladares and Andreas Berg of the Centre for Medical Physics and Biomedical Technology of MedUni Vienna as Inventors of the Year 2022.

The Special Research Area (SFB) "Histone Deacetylases (HDACs) as Regulators of T-Cell-Mediated Immunity in Health and Disease", coordinated by MedUni Vienna, was extended for an additional four years at the most recent meeting of the FWF Board of Trustees. The research network led by Wilfried Ellmeier from MedUni Vienna's Centre for Pathophysiology, Infectiology and Immunology will thus be able to continue its successful path established in recent years.

A MedUni Vienna research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequisites for optimal use of this novel therapy for lymphoma treatment. The current findings are an essential step forward towards optimizing this promising therapy. The results of the study were recently published in the top journal "Frontiers in Immunology".

Severe covid 19 disease is characterized by excessive immune and inflammatory processes in the body. Conversely, long covid syndrome is likely to have a strong anti-inflammatory immune status. Scientists have now found this out with extensive blood plasma analyses of vaccinated persons without subsequent disease, persons with completely survived covid 19 infection and long covid patients. The scientific work of the team led by study director Christopher Gerner from the Faculty of Chemistry at the University of Vienna and researchers from MedUni Vienna has now been published as a pre-proof in the open access online journal "iScience".

MedUni Vienna's Department of Anaesthesia, General Intensive Care Medicine and Pain Therapy is the first hospital in Austria to become a certified Data Partner with the EHDEN project. This highlights the clinic's position as a leading institution in the field of data science and big data.

Medicine & Science Alcohol-related liver disease is among the most common causes of morbidity and mortality worldwide. Due to an incomplete understanding of the factors contributing to disease development, liver transplantation is still the only available cure.

Medicine & Science Christoph Bock's team at the CeMM Research Center for Molecular Medicine at the Austrian Academy of Sciences and the Institute of Artificial Intelligence of MedUni Vienna established a catalog of DNA methylation across 580 animal species.

Medicine & Science Medical science has not yet been able to explain why the Epstein-Barr virus triggers infectious mononucleosis (IM) in some people with initial infections and not in others. But now, a research team led by Elisabeth Puchhammer-Stöckl, head of the Center for Virology at MedUni Vienna, has identified a specific immune response to the virus as the cause, and as a potential target for the development of vaccines.

University The enormous challenges posed to Austria by the issue of nursing and the shortage of nursing staff are being met by the association "Caregiver with a Heart" and the Medical University of Vienna with the establishment of an endowed professorship for nursing scienc.

Mario Rothbauer from MedUni Vienna's Department of Orthopaedics and Trauma Surgery conducted research in the USA on a prestigious Fulbright scholarship. He joined the Hospital for Special Surgery to work on his project "Hoffa-fibrosis-on-a-chip in osteoarthritis".

Cervical cancer is the cancer with the fourth highest mortality rate among women worldwide. Locally advanced cervical cancer (LACC) is treated with a combination of external and internal radiotherapy (brachytherapy) and chemotherapy. For the first time, a study conducted by a research group at the Comprehensive Cancer Centre Vienna of MedUni Vienna and Vienna General Hospital using data from the multicentre EMBRACE-I trial demonstrated the superiority of a targeted approach in brachytherapy. The results have just been published online in the highly respected Journal of Clinical Oncology and are the basis for customized treatment for patients.

Javier Martinez, research group leader at the joint Max Perutz Laboratories of MedUni Vienna and the University of Vienna, is coordinating the project "RNA@core: Molecular Mechanisms in RNA Biology", which has been awarded an extensive "doc.funds" grant by the Austrian Science Fund FWF. This grant is used for target-specific doctoral training with a focus on RNA biochemistry.

Christoph Huber, vaccination pioneer, co-founder of BioNTech and member of the Scientific Advisory Board of MedUni Vienna, has been awarded the Werner von Siemens Ring 2022. The Werner-von-Siemens Ring is a prestigious German award for personalities who have significantly advanced technical science through their achievements or who have opened up new paths as researchers. The ring was awarded by the Werner-von-Siemens-Ring Foundation at a ceremony at the Berlin-Brandenburg Academy of Sciences and Humanities.